BETTER BIOMARKERS FOR PREDICTING THE INCIDENCE OF HAVING ATHEROSCLEROSIS AND HEART ATTACKS
With
Associate Professor Christina Bursill
Co-Director, Vascular Research Centre,
South Australian Health and Medical Research Institute (SAHMRI) &
Department of Health and Medical Science,
The University of Adelaide, Australia
RESEARCHER PROFILE
Filmed in Adelaide, Australia | April 2025
Associate Professor Christina Bursill started as Co-director of the Vascular Research Centre in January 2017 at the South Australian Health and Medical Research Institute (SAHMRI) and at The University of Adelaide, Department of Health and Medical Science. She currently holds the Lin Huddleston National Heart Foundation fellowship and is a Chief Investigator on the ARC Centre of Excellence for Nanoscale Biophotonics (CNBP).
Assoc Prof Bursill is a vascular biologist with interests and expertise in vascular inflammation, atherosclerosis and angiogenesis. She completed her PhD at The University of Adelaide in lipid metabolism then headed to Oxford University for five years to undergo a postdoctoral post in the Departments of Cardiovascular Medicine and Pathology. Her postdoctoral time triggered her interest in the mechanisms that cause atherosclerosis and in particular the role of small inflammatory proteins called chemokines.
Assoc Prof Bursill returned to Australia in 2007 at the Heart Research Institute (HRI) in Sydney where she led the Immunobiology Group. In 2008, she was awarded a National Heart Foundation Career Development Fellowship. At the HRI A/Prof Bursill developed an interest in high-density lipoproteins (HDL) and through NHMRC and National Heart Foundation funding, investigated novel mechanisms of their action in models of stent biocompatibility, diabetes and wound healing. She also has an interest in using viral gene transfer techniques to over-express proteins that attenuate chemokine activity to suppress atherosclerosis and inflammatory-driven diseases. A/Prof Bursill currently holds NHMRC Ideas, Heart Foundation Vanguard and Diabetes Australia Millenium grant funding.
Recently, Christina has been focusing on finding ways to reduce atherosclerotic heart disease.
Source: Supplied
https://orcid.org/0000-0002-0682-8760
-
Identification & characterisation of molecular drivers of therapeutic resistance
Professor Pieter Eichhorn is an internationally experienced cancer biologist and research leader whose career has been defined by high-impact contributions at the interface of functional genomics, translational oncology, and research infrastructure strategy.
He completed his PhD at the University of Newcastle upon Tyne, contributing to the cloning of the gene associated with Cornelia de Lange Syndrome, before undertaking postdoctoral training at the Netherlands Cancer Institute in the laboratory of René Bernards. There, he performed pioneering functional genetic screens that identified key regulators of oncogenesis and therapy resistance, including critical roles for the PI3K signalling pathway in resistance to targeted breast cancer therapies.
-
Anaemia guidelines updated after 50 years
Professor Sant-Rayn Pasricha is the Acting Deputy Director at the Walter Eliza Hall Institute of Medical Research in Melbourne, Australia. He is also a clinical haematologist at the Royal Melbourne Hospital and the Peter MacCallum Cancer Centre. From a young age, Prof Pasricha dreamed of becoming a doctor and found joy in learning about the human body and how to care for patients. After completing medical school, he developed a passion for working in low and middle-income countries, which led him to spend time working in East Timor, India, and Central Australia with First Nations communities.
-
Dr Ryan O’Hare Doig
NEIL SACHSE CENTRE FOR SPINAL CORD RESEARCH (SAHMRI)
SOUTH AUSTRALIA
AUSTRALIA
